Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A review of the ethics of the use of placebo in clinical trials for relapsing-remitting multiple sclerosis therapeutics.
Neuromyelitis optica relapses: Race and rate, immunosuppression and impairment.
Haematopoietic stem cell transplantation in autoimmune diseases: From basic science to clinical practice.
Subcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathies.
The emerging role of the cannabinoid receptor family in peripheral and neuro-immune interactions.
Neurofilament in CSF-A biomarker of disease activity and long-term prognosis in multiple sclerosis.
Autoinjector preference in multiple sclerosis and the role of nurses in treatment decisions: results from an international survey in Europe and the USA.
Opportunities and considerations for visualising neuroimaging data on very large displays.
Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013.
Diagnostic Criteria, Classification and Treatment Goals in Multiple Sclerosis: The Chronicles of Time and Space.
The High Prevalence of the Varicella Zoster Virus in Patients With Relapsing-Remitting Multiple Sclerosis: A Case-Control Study in the North of Iran.
Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: Yes.
Insights into the Pathogenesis and Treatment of Krabbe Disease.
Upper Respiratory Infections and MRI Activity in Relapsing-Remitting Multiple Sclerosis.
Health in times of uncertainty in the eastern Mediterranean region, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
BK virus encephalopathy and sclerosing vasculopathy in a patient with hypohidrotic ectodermal dysplasia and immunodeficiency.
Capacity for financial decision making in multiple sclerosis.
Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice.
Humoral response against myelin associated glycoprotein reflects oligodendroglial degeneration in Parkinson's disease.
A Randomized Crossover Trial of Dalfampridine Extended Release for Effect on Ambulatory Activity in People with Multiple Sclerosis.
Association between seasonal factors and multiple sclerosis.
Multiple sclerosis should be treated using a step-down strategy rather than a step-up strategy-NO.
The Adaptor Protein Rai/ShcC Promotes Astrocyte-Dependent Inflammation during Experimental Autoimmune Encephalomyelitis.
Multiple sclerosis should be treated using a step-down strategy rather than a step-up strategy-YES.
Survival and Functionality of Human Induced Pluripotent Stem Cell-Derived Oligodendrocytes in a Nonhuman Primate Model for Multiple Sclerosis.

Pages